Turkova, Anna; Waalewijn, Hylke; Chan, Man K; Bollen, Pauline DJ; Bwakura-Dangarembizi, Mutsa F; Kekitiinwa, Adeodata R; Cotton, Mark F; ... Zuidewind, Peter; + view all (2022) Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. The Lancet HIV 10.1016/s2352-3018(22)00160-6. (In press). Green open access